| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 03, 2024 | Option Exercise | $0.50 | 11,838 | 5,873 | 84,758 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jul 03, 2023 | Option Exercise | $0.36 | 10,305 | 3,710 | 96,596 | Jul 05, 2023, 06:59 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Apr 13, 2023 | Buy | $0.29 | 10,000 | 2,900 | 106,901 | Apr 14, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Apr 12, 2023 | Buy | $0.29 | 15,000 | 4,350 | 96,901 | Apr 14, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 03, 2023 | Option Exercise | $1.02 | 6,091 | 6,213 | 81,901 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 27, 2022 | Buy | $1.78 | 8,500 | 15,130 | 39,867 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 28, 2022 | Buy | $1.63 | 5,000 | 8,150 | 44,867 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jun 11, 2021 | Buy | $5.45 | 1,500 | 8,175 | 1,500 | Jun 15, 2021, 06:00 PM | |
| LCTX | Lineage Cell Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Aug 13, 2019 | Buy | $1.02 | 5,000 | 5,100 | 5,000 | Aug 15, 2019, 08:42 AM |
Menu